期刊文献+

白细胞介素-1α-889C/T多态性与小儿癫痫易感性的关系 被引量:4

Association of IL-1α-889C/T polymorphism with the risk of pediatric epilepsy
下载PDF
导出
摘要 目的:探讨白细胞介素-1α-889C/T多态性与小儿癫痫易感性关系。方法:采用病例对照研究,选择117例小儿癫痫患者和95例健康儿童,应用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)进行IL-1α-889C/T多态性检测,比较不同基因型与小儿癫痫风险的关系。结果:与携带-889CC基因型者比较,携带至少1个-889 T等位基因者(即CT和TT基因型)小儿癫痫风险增加2.91倍(95%CI=1.27~6.69),且有癫痫或热性惊厥家族史者,-889突变型使小儿癫痫风险增加6.83倍(95%CI=2.30~20.29)。结论:IL-1α-889C/T多态性可能与小儿癫痫遗传易感性有关,并可显著增加家族史对小儿癫痫的危险性。 Objective:To explore the relationship between IL-1α-889C/T polymorphism and the susceptibility to pediatric epilepsy. Methods:IL-1α-889C/T polymorphism in 117 patients with pediatric epilepsy and 95 healthy individuals controls were analyzed with polymerase chain reaction restriction and fragment length polymorphism (PCR-RFLP). Results: Multivariate Logistic regression analysis revealed that individuals carrying at least one -889 T variant allele (CT + TT genotypes) had a significant increased risk for pediatric epilepsy (adjusted OR = 2.91,95% CI: 1.27-6.69) , compared with the wild-type genotype (-889CC) . Furthermore, individuals with epilepsy or febrile seizures family history had a significantly higher risk (adjusted OR = 6.83, 95% CI: 2.30-20.29), compared with those with both CC genotypes. Conclusion:These findings support the hypothesis that IL-1α-889C/T polymorphism may contribute to the risk of developing pediatric epilepsy.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2009年第8期1153-1156,共4页 Journal of Nanjing Medical University(Natural Sciences)
基金 南京医科大学科技发展基金项目(07NMUM078)
关键词 小儿癫痫 Interleukin-1α基因 多态性 PCR-RFLP pediatric epilepsy interleukin-1α gene polymorphism PCR-RFLP
  • 相关文献

参考文献14

  • 1Senay Haspolat, Yunus Baysal, Ozgur Duman, et al. Interleukin-1a,Interleukin-1β, and Interleukin-1Ra Polymorphisms in Febrile Seizures [J]. Journal of Child Neurology,2005,20(7) :565-568.
  • 2李艳,徐朴,张平安,李晓艳,黄从新.白细胞介素-1基因多态性与高血压易感性的研究[J].中华医学遗传学杂志,2004,21(5):491-493. 被引量:8
  • 3Fisher RS,van Emde Boas W,Blune W,et al. Epileptic seizures and epilepsy:definition proposed by the ILAE and the International Bureau for Epilespy (IBE) [J]. Epilepsia, 2005,46(4) : 470-472.
  • 4Wang CY,Shen YC,Lo FY,et al. Polymorphism in the IL-1 alpha(-889) locus associated with elevated risk of primary open angle glaucoma [J]. Mol Vis,2006,15 (12): 1380-1385.
  • 5杨婕,沈洪兵,沈靖,钮菊英,胡志斌,徐耀初.IL-1B-31及IL-1RN基因多态性与胃癌易感性关系[J].南京医科大学学报(自然科学版),2004,24(3):193-197. 被引量:3
  • 6Allan SM,Tyrrel PJ,Rothwell N3. Interleukin-1 and neuronal injury[J]. Nat Rev Immunol, 2005,5(8):629-640.
  • 7Voutsinos-Porche B, Koning E, Kaplan H, et al. Temporal patterns of the cerebral inflammatory response in the rat lithium-pilocarpine model of temporal lobe epilepsy [J]. Neurobiol Dis, 2004, 17(3) :385-402.
  • 8Chang SY,Su PF,Lee TC. Ectonic expression of interleukin-1 receptor type Ⅱ enhances cell migration through activation of the pre-interleukin 1 alpha pathway[J]. Cytokine, 2009,45 ( 1 ) : 32-38.
  • 9Dursun E,Gezen-AK D,Ertan T,et al. Interleukin-1 al- pha-889 C/T polymorphism in Turkish patients with lateonset Alzheimer's disease[J]. Dement Geriatr Cogn Disord, 2009,27 ( 1 ) : 82-87.
  • 10Tsakiri N, Kimber I, Rothwell NJ, et al. Differential effects of interleukin-1 alpha and beta on interleukin-6 and chemokine synthesis in neurones [J]. Mol Cell Neurosci, 2008,38 (2) : 259-65.

二级参考文献15

  • 1Suerbaum Sebastian, Michetti Pierre. Medical progress:Helicobacter pylori infection[J]. N Engl J Med, 2002, 347(15):1175-1186.
  • 2William P Arend, Carla J Guthridge. Biological role of interleukin 1 receptor antagonist isforms[J]. Ann Rheum Dis, 2000, 59(suppl I):160-164.
  • 3El-omar. The importance of interleukin 1 beta in Helicobacter pylori assciated disease[J]. Gut, 2001, 48:743-747.
  • 4El-omar, Mary Canington, Chow WH, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer[J]. Nature, 2000, 404: 398-402.
  • 5Jose Carlos Machado, Paul Pharoah, Sonia Sousa, et al.Interleukin-1B and interleukin 1RN polymorphisms are assciated with increased risk of gastric carcinoma[J]. Gastroenterology, 2001, 121:823-829.
  • 6Ming-Shiang Wu, Chun-Ying Chen, Ming-Tsan Lin, et al.Interleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwan Residents Chinese[J]. Int J Cancer, 2003,104:617-623.
  • 7Peeters AC, Netea MG, Janssen MC, et al. Pro-inflammatory cytokines in patients with essential hypertension. Eur J Clin Invest,2001,31:31-36.
  • 8Dalekos GN, Elisaf M, Bairaktari E, et al. Increased serum levels of interleukin-1 beta in the systemic circulation of patients with essential hypertension:additional risk factor for atherogenesis in hypertensive patients? J Lab Clin Med,1997,129:300-308.
  • 9Vamvakopoulos J, Green C, Metcalfe S. Genetic control of IL1beta bioactivity through differential regulation of the IL-1 receptor antagonist. Eur J Immunol,2002,32:2988-2996.
  • 10Zhang PA, Huang XZ, Li D, et al. Association between estrogen receptor gene polymorphisms and serum lipid in Chinese Han population. Chin J Med Genet, 2001, 18:324-326.[张平安,黄宪章,李栋,等. 中国汉族人群雌激素受体基因多

共引文献9

同被引文献38

  • 1癫痫的病因及发病机制的新进展[J].中国实用儿科杂志,2000,15(9):521-523. 被引量:1
  • 2Yong Yong SHI,Lin HE.SHEsis,a powerful software platform for analyses of linkage disequilibrium,haplotype construction,and genetic association at polymorphism loci[J].Cell Research,2005,15(2):97-98. 被引量:382
  • 3王晶,路毅,邢秀荣,秦俭,王蓉,盛树力.APP17肽对心肺复苏大鼠海马神经元NGF、BDNF表达的影响[J].中国药理学通报,2007,23(5):582-585. 被引量:9
  • 4程国彭.医学心悟[M].北京:人民卫生出版社,1959:140.
  • 5Flesch G.Overview of the clinical pharmacokinetics of oxcarbazepine. Clin Drug Investig . 2004
  • 6Juenke JM,,Brown PI,Urry FM,et al.Drug monitoring and toxicology:a procedure for the monitoring of oxcarbazepine metabolite by HPLC-UV. Journal of Chromatographic Science . 2006
  • 7Srinubabu G,Ratnam BV,Rao AA,et al.Development and validation of LC-MS/MS method for the quantification of oxcarbazepine in human plasma using an experimental design. Chemical and Pharmaceutical Bulletin . 2008
  • 8Souppart C,Yin Q,Merz M,et al.Bioequivalence of oxcarbazepine oral suspension vs.film-coated tablet in healthy Chinese male subjects. International Journal of Clinical Pharmacology Research . 2008
  • 9Hunek C,Burgyan M,Wang S.Measurement of10,11-dihydro-10-hydroxy-carbamazepine in serum and plasma by high-performance liquid chromatography. Clinical Chemistry and Laboratory Medicine . 2008
  • 10Coppola G,Franzoni E,Verrotti A,et al.Levetiracetam or oxcarbazepine as monotherapy in newly diagnosed benign epilepsy of childhood with centrotemporal spikes(BECTS):an open-label,parallel group trial. Brain and Development . 2007

引证文献4

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部